远程康复在人工髋关节置换术患者中的应用效果研究

注册号:

Registration number:

ChiCTR2300068797 

最近更新日期:

Date of Last Refreshed on:

2023-07-31 17:01:59 

注册时间:

Date of Registration:

2023-03-01 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

远程康复在人工髋关节置换术患者中的应用效果研究

Public title:

Research on the effectiveness of telerehabilitation in patients undergoing artificial hip arthroplasty

注册题目简写:

English Acronym:

研究课题的正式科学名称:

远程康复在人工髋关节置换术患者中的应用效果研究

Scientific title:

Research on the effectiveness of telerehabilitation in patients undergoing artificial hip arthroplasty

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王琴潞 

研究负责人:

钱文伟 

Applicant:

Qinlu Wang 

Study leader:

Wenwei Qian 

申请注册联系人电话:

Applicant telephone:

+86 157 3501 2336

研究负责人电话:

Study leader's
telephone:

+86 10 6915 2710

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

oukinro@163.com

研究负责人电子邮件:

Study leader's E-mail:

qianww007@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市石景山区八大处33号

研究负责人通讯地址:

北京市东城区帅府园一号

Applicant address:

33 Badachu Road, Shijingshan District, Beijing

Study leader's address:

1 Shuaifuyuan Wangfujing Dongcheng District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国医学科学院北京协和医学院护理学院

Applicant's institution:

Chinese Academy of Medical Sciences & School of Nursing Peking Union Medical College

研究负责人所在单位:

中国医学科学院北京协和医院

Affiliation of the Leader:

Chinese Academy of Medical Sciences & Peking Union Medical College Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

I-23PJ147

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国医学科学院北京协和医院伦理审查委员会

Name of the ethic committee:

Ethics Review Committee of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

伦理委员会批准日期:

Date of approved by ethic committee:

2023-01-20 00:00:00

伦理委员会联系人:

李佳月

Contact Name of the ethic committee:

Jiayue Li

伦理委员会联系地址:

北京市东城区帅府园1号

Contact Address of the ethic committee:

1 Shuaifuyuan Wangfujing Dongcheng District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中国医学科学院北京协和医院

Primary sponsor:

Chinese Academy of Medical Sciences & Peking Union Medical College Hospital

研究实施负责(组长)单位地址:

北京市东城区帅府园1号

Primary sponsor's address:

1 Shuaifuyuan Wangfujing Dongcheng District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

中国医学科学院北京协和医院

具体地址:

北京市东城区帅府园1号

Institution
hospital:

Chinese Academy of Medical Sciences & Peking Union Medical College Hospital

Address:

1 Shuaifuyuan Wangfujing Dongcheng District, Beijing

经费或物资来源:

上海复动医疗管理有限公司

Source(s) of funding:

Shanghai Fudong Medical Management Co., Ltd.

研究疾病:

人工髋关节置换术后  

Target disease:

total hip replacement

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1.本研究的目的是评估移动应用程序联合智能可穿戴设备的远程康复系统在人工髋关节置换术后应用的可行性,并将其临床结果与常规康复进行比较。 2.为髋关节置换术患者开展远程康复护理提供实践参考。  

Objectives of Study:

1. The aim of this study was to evaluate the feasibility of a remote rehabilitation system based on a mobile app combined with a smart wearable device after total hip arthroplasty (THA) and to compare its clinical outcomes with conventional rehabilitation. 2. To provide practical reference for telerehabilitation nursing for patients with hip replacement.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.行关节翻修术或双侧关节置换术;
2.术后3个月内将接受其他下肢手术;
3.伴有严重的心、肺、肝、肾等重要脏器疾病;
4.伴有手术部位以外的其他限制肢体活动的神经系统或骨骼肌肉系统疾病;
5.术后病情不稳定,发生严重并发症。

Exclusion criteria:

1. Revision or bilateral arthroplasty;
2. Will receive other lower limb surgery within 3 months after operation;
3. Accompanied by serious heart, lung, liver, kidney and other important organ diseases;
4. with other neurological or musculoskeletal diseases outside the surgical site that limit limb movement;
5. Unstable postoperative condition and serious complications occurred.

研究实施时间:

Study execute time:

From 2023-03-01 00:00:00 To 2024-02-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-03-01 00:00:00 To 2024-02-01 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

35

Group:

Experimental group

Sample size:

干预措施:

远程康复

干预措施代码:

Intervention:

telerehabilitation

Intervention code:

组别:

对照组

样本量:

35

Group:

Control group

Sample size:

干预措施:

传统康复

干预措施代码:

Intervention:

traditional rehabilitation

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

中国医学科学院北京协和医院 

单位级别:

三甲 

Institution
hospital:

Chinese Academy of Medical Sciences & Peking Union Medical College Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

Harris髋关节评分

指标类型:

主要指标

Outcome:

Harris Hip Score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

髋关节功能障碍与骨性关节炎评分简版

指标类型:

次要指标

Outcome:

HOOS-12

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

欧洲五维五水平健康量表

指标类型:

次要指标

Outcome:

EQ-5D-5L

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疼痛数字评分

指标类型:

次要指标

Outcome:

Numerical Rating Scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

依从性

指标类型:

次要指标

Outcome:

compliance

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

系统可用性量表

指标类型:

次要指标

Outcome:

System Usability Scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 75 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由专业统计学人员使用SPSS生成随机数集;再由一名不参与实施及观察的研究人员利用密封信封法对研究对象分组。

Randomization Procedure (please state who generates the random number sequence and by what method):

A random number set was generated by a professional statistician using SPSS; the participants were then grouped by a researcher who was not involved in the implementation and observation using the sealed envelope method.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

联系研究负责人邮箱:qianww007@163.com

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Contact the study leader at qianww007@163.com

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

由一名研究者填写CRF表,另一名研究者核对。数据储存于医院局域网服务器内

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

A CRF form was completed by one investigator and checked by another. Data stored in hospital LAN server

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-03-01 09:35:42